Red Kross
Red Kross
Overview
Red Kross is a CBD-hemp hybrid strain developed by Pharmers Hemp created in Alaska by crossing Baox and Finola. It is an F3 cross between the Baox and Finola varieties, with both male and female plants hand selected from thousands of plants in the field for their individual phenotypes. This strain represents a significant achievement in hemp breeding, being developed as part of the movement toward CBD-focused varieties with virtually no psychoactive effects. The ratio CBD to THC is approximately 20:1 with some phenotypes expressing ratios of 30:1, making it an ideal strain for therapeutic applications without intoxicating effects. The Red Kross cultivar is a CBD-hemp hybrid strain and serves as a parent of the Blue Kross medical marijuana strain, demonstrating its importance in the development of other therapeutic varieties. The strain inherits hardy characteristics from its parent genetics, with Baox contributing durability and cannabinoid production, while Finola brings autoflowering traits and early maturation.
Effects
Reported Medical Uses
- Users report relief from pain
- May help with inflammation
- Often used for anxiety relief
- Potential anti-spasmodic properties
This is not medical advice. Consult a healthcare professional.
Possible Negative Effects
- Minimal due to low THC content
- Possible mild drowsiness
Growing Information
Red Kross takes anywhere from 90 to 110 days to harvest depending on the phenotype. This strain is suitable for both indoor and outdoor cultivation, inheriting hardiness from its Baox parent which provides durability against variable weather conditions. The Finola genetics contribute autoflowering characteristics, making cultivation more predictable and manageable. Plants typically reach moderate height and produce decent yields for hemp varieties. Growers should monitor THC levels carefully to maintain compliance with hemp regulations, as environmental stress can potentially increase THC content.